…
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. The company offers flowers, extracts, concentrates, edibles, pre-rolls, infused blunts, cannabis-infused gummies and chocolates, tinctures, capsules, softgels, and topical products, as well as vaporization devices and cartridges under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, and Sèche brands. It also engages in the sale of bulk raw materials to third parties. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Jushi Holdings Inc operates a vertically integrated cannabis business in the United States, engaged in cultivation, processing, wholesale distribution and branded retail across multiple state-licensed markets. Long-term growth drivers include expanding state-level legalization, scaling retail footprint and branded product distribution, and potential operational efficiencies from vertical integration, which may benefit revenue and market share as the legal market matures.
Key investment risks include continued federal illegality and state regulatory variability, ongoing unprofitability and capital-raising needs, and intense competition in licensed markets.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -33.60M | -17.15M | -33.30M | -193.88M | 52.45M |
| Minority interest | - | - | 0.00M | 2.35M | 2.77M |
| Net income | -68.59M | -48.78M | -65.10M | -202.32M | 24.14M |
| Selling general administrative | 78.26M | 79.08M | 84.10M | 156.17M | 101.69M |
| Gross profit | 113.98M | 118.30M | 116.23M | 95.48M | 87.37M |
| Reconciled depreciation | 30.99M | 29.89M | 26.59M | 26.49M | 9.47M |
| Ebit | - | - | - | -59.48M | -29.07M |
| Ebitda | - | - | - | -121.65M | 93.12M |
| Operating income | 2.18M | 11.29M | 5.76M | -60.69M | -21.16M |
| Interest expense | 41.30M | 37.98M | 37.06M | 45.73M | 31.20M |
| Tax provision | 34.99M | 31.63M | 31.81M | 8.45M | 31.09M |
| Interest income | 0.46M | 0.56M | 0.09M | 0.14M | 0.24M |
| Net interest income | -40.84M | -37.42M | -36.97M | -45.59M | -30.96M |
| Income tax expense | - | - | - | - | 29.62M |
| Total revenue | 262.91M | 257.52M | 269.44M | 284.28M | 209.29M |
| Total operating expenses | 260.73M | 246.23M | 263.69M | 344.97M | 230.45M |
| Cost of revenue | 148.93M | 139.22M | 153.22M | 188.81M | 121.92M |
| Total other income expense net | 5.07M | 8.98M | -2.09M | -87.60M | 104.57M |
| Net income from continuing ops | -68.59M | -48.78M | -65.10M | -202.32M | 21.36M |
| Net income applicable to common shares | - | - | - | - | 20.25M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 422.34M | 440.32M | 463.39M | 529.34M | 677.91M |
| Intangible assets | 92.20M | 100.47M | 95.97M | 100.08M | 182.47M |
| Other current assets | 2.11M | 1.79M | 1.01M | 0.55M | 1.68M |
| Total liab | 537.69M | 490.56M | 471.01M | 483.45M | 494.82M |
| Total stockholder equity | -115.34M | -50.23M | -6.23M | 47.28M | 184.48M |
| Other current liab | 0.30M | - | 3.23M | 30.79M | 20.52M |
| Common stock | - | - | - | - | 424.79M |
| Capital stock | 511.87M | 508.39M | 503.61M | 492.02M | 427.32M |
| Retained earnings | -627.21M | -558.62M | -509.84M | -444.74M | -242.42M |
| Other liab | - | - | - | 77.34M | 163.88M |
| Good will | 30.91M | 30.91M | 30.91M | 38.24M | 75.33M |
| Other assets | - | - | - | 11.97M | 9.32M |
| Cash | 24.05M | 19.52M | 26.03M | 26.20M | 94.96M |
| Total current liabilities | 66.19M | 68.89M | 162.46M | 107.63M | 83.93M |
| Net debt | 181.79M | 166.69M | 186.53M | 163.07M | 32.26M |
| Short long term debt | 6.64M | 2.76M | 86.51M | 8.70M | 2.11M |
| Other stockholder equity | - | - | - | - | 24.96M |
| Property plant equipment | - | - | - | 308.02M | 248.58M |
| Total current assets | 68.31M | 72.15M | 81.64M | 70.05M | 154.36M |
| Long term investments | - | 0.00M | 0.20M | 0.98M | 1.50M |
| Net tangible assets | - | - | - | -91.04M | -55.92M |
| Short term investments | - | - | - | - | 0.00M |
| Net receivables | 2.80M | 1.46M | 3.38M | 4.81M | 3.20M |
| Long term debt | 199.19M | 183.45M | 126.04M | 180.56M | 125.11M |
| Inventory | 34.61M | 36.14M | 33.59M | 35.09M | 43.32M |
| Accounts payable | 22.33M | 21.46M | 15.38M | 32.93M | 18.55M |
| Non currrent assets other | 2.97M | 6.79M | 9.13M | 26.09M | 3.67M |
| Non current assets total | 354.03M | 368.17M | 381.76M | 459.29M | 514.60M |
| Capital lease obligations | 87.57M | 84.92M | 86.28M | 131.94M | 118.87M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.00M | -5.21M | -13.80M | -80.86M | 9.15M |
| Change to liabilities | - | - | - | 24.11M | 21.56M |
| Total cashflows from investing activities | - | - | - | -80.86M | -113.45M |
| Net borrowings | 2.65M | -21.44M | 13.29M | 16.75M | 36.58M |
| Total cash from financing activities | 0.77M | -24.46M | 15.12M | 33.98M | 137.66M |
| Change to operating activities | - | - | - | 3.36M | -3.90M |
| Net income | -68.59M | -48.78M | -65.10M | -202.32M | 25.74M |
| Change in cash | 5.27M | -9.96M | -1.54M | -68.34M | 9.63M |
| Begin period cash flow | 21.35M | 31.30M | 32.01M | 95.49M | 85.86M |
| End period cash flow | 26.62M | 21.35M | 30.29M | 27.15M | 95.49M |
| Total cash from operating activities | 17.73M | 21.57M | -3.04M | -21.42M | -14.30M |
| Issuance of capital stock | - | - | 0.00M | 13.68M | 85.66M |
| Depreciation | 30.99M | 29.89M | 30.61M | 26.49M | 8.41M |
| Other cashflows from investing activities | - | - | - | -3.00M | -3.00M |
| Dividends paid | - | - | - | - | 0.00M |
| Change to inventory | 1.76M | -4.01M | -11.53M | 5.40M | -12.95M |
| Change to account receivables | -1.13M | 1.86M | -3.04M | -1.59M | -1.87M |
| Other cashflows from financing activities | - | - | - | 2.35M | -1.70M |
| Change to netincome | - | - | - | 123.15M | -45.81M |
| Capital expenditures | 17.29M | 4.71M | 16.04M | 56.88M | 75.30M |
| Change in working capital | 2.67M | 6.19M | -5.37M | 31.27M | 37.55M |
| Stock based compensation | 2.10M | 4.22M | 11.69M | 23.07M | 13.41M |
| Other non cash items | 13.76M | 8.45M | 30.38M | 40.36M | 22.55M |
| Free cash flow | 0.43M | 16.86M | -19.08M | -78.30M | -72.74M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| JUSH Jushi Holdings Inc |
0.05 5.88% |
0.90 | - | 17.86 | 0.52 | 0.69 | 1.41 | 9.56 |
| GTII Green Thumb Industries Inc |
-0.09 0.82% |
10.95 | 14.70 | 34.84 | 1.91 | 0.86 | 1.61 | 3.95 |
| CL Cresco Labs Inc |
0.03 2.91% |
1.06 | - | 105.26 | 0.70 | 0.99 | 1.32 | 42.44 |
| GRIN Grown Rogue International Inc |
0.05 8.93% |
0.61 | 23.50 | - | 3.62 | 4.10 | 3.13 | 11.19 |
| AAWH-U Ascend Wellness Holdings Inc. |
0.03 5.36% |
0.59 | - | 10.88 | 0.22 | 59.95 | 1.23 | 7.98 |
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. The company offers flowers, extracts, concentrates, edibles, pre-rolls, infused blunts, cannabis-infused gummies and chocolates, tinctures, capsules, softgels, and topical products, as well as vaporization devices and cartridges under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, and Sèche brands. It also engages in the sale of bulk raw materials to third parties. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.
| Name | Title | Year Born |
|---|---|---|
| Mr. James Anthony Cacioppo | Founder, Chairman & CEO | 1963 |
| Mr. Louis Jonathan Barack | Founder, President, Chief Revenue Officer & Corporate Secretary | 1977 |
| Ms. Michelle O. Mosier | CFO & Chief Accounting Officer | 1965 |
| Mr. Ian Farrell | Vice President of Compliance | NA |
| Ms. Toya Bellamy-Lockhart | Executive Vice President of Human Resources | NA |
| Mr. Trenton Woloveck | Co-Chief Strategy Director | 1985 |
| Mr. Matthew Leeth | Chief Regulatory Director & Senior Executive Counsel | NA |
| Mr. Andreas Neumann | Chief Creative Director | NA |
| Mr. Harris Shain | Co-Chief Strategy Director | NA |
| Ms. Lisa Forman | Vice President of Investor Relations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.